Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
European Medical Journal

Inpatient COPD Care Pathway Boosts Key Hospital Metrics

An inpatient COPD care pathway embedded in the EHR was linked to shorter hospital stays, lower costs, more pulmonary ...
Finger Lakes Times

Is a Nebulizer Right for Your Chronic Lung Disease?

If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...

National COPD Awareness Month sheds light on the disease's leading causes and symptoms

November is National COPD Awareness Month. This month is meant to bring attention to the disease as it's one of the leading ...